Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation.

about

Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation.

Item

http://www.wikidata.org/entity/Q38749310

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effect of prior hepatitis B vi ...... s after liver transplantation.

@en

type

Item

label

Effect of prior hepatitis B vi ...... s after liver transplantation.

@en

prefLabel

Effect of prior hepatitis B vi ...... s after liver transplantation.

@en

P1476

Effect of prior hepatitis B vi ...... s after liver transplantation.

@en

P2093

Ahmet Gurakar

http://www.w3.org/2001/XMLSchema#string

Andrew M Cameron

http://www.w3.org/2001/XMLSchema#string

Berkeley N Limketkai

http://www.w3.org/2001/XMLSchema#string

Brian Kim

http://www.w3.org/2001/XMLSchema#string

Dorry L Segev

http://www.w3.org/2001/XMLSchema#string

Muge Pirtini-Cetingul

http://www.w3.org/2001/XMLSchema#string

Murat T Gulsen

http://www.w3.org/2001/XMLSchema#string

Panagiotis Trilianos

http://www.w3.org/2001/XMLSchema#string

Po-Hung Chen

http://www.w3.org/2001/XMLSchema#string

Tinsay A Woreta

http://www.w3.org/2001/XMLSchema#string

P2860

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Molecular biology of hepatitis B virus infection

Chronic hepatitis B: update 2009

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

Reactivation of hepatitis B.

Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.

P304

579-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CTR.12723

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26913379

http://www.w3.org/2001/XMLSchema#string